Abstract Two widely used active pharmaceutical ingredients (API), ambroxol hydrochloride (AMB·HCl) and bromhexine (BMH·HCl), belong to the expectorant mucokinetic group of drugs. Their applications are found in treatment upper respiratory tract bronchopulmonary diseases. The compounds have similar chemical structures, but different enough distinguish their physicochemical properties. To underst...